Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Alex Bour leads Evaluate’s Competitive Intelligence consulting practice, working closely with clients to help them to understand the nuances of their competitive…
The first half of the year showed some promise. Did the third quarter continue the trend? Well...
Digital health may be the new(ish) kid on the block of the wider pharma landscape, but in the past year or so it’s been through a pretty rapid maturity process. As with…
Got time for a quick brain break? Listen to our podcast where we discuss the catalysts that will shape the third quarter of 2022.
To those beyond the world of biopharma, the term “orphan drug” sounds a bit sad, a bit forgotten. But to those involved in the industry, the superior return on…
Once upon a time, a gene therapy player could release data on a handful of subjects and see its share price rocket. The sector was riding high after the landmark…